In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...

FORE Biotherapeutics has announced that its plixorafenib abstract has been selected for poster presentation at the highly ...

The presence of dozens of students displaying their research via posters and other presentation media on Saturday, May 3 ...

The popular symposium, which celebrates undergraduate research across all disciplines, transformed the Hassenfeld Conference ...

Weill Cornell Medicine Qatar (WCM Q) recently hosted its second annual Student Research Forum, showcasing 66 impressive ...

The University at Albany hosted its third annual Showcase Day, recognizing the creative and innovative work of students ...

Higher patient-reported convenience and effectiveness of ALXN1840 compared to standard of care, including those who transitioned from standard of care to ALXN1840 in the extension portion of the Phase ...

Forge Biologics ("Forge"), a leading manufacturer of genetic medicines and member of the Ajinomoto Bio-Pharma Services group, ...

Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the ...

Discover groundbreaking research and presentations from leading companies at the ARVO 2025 Annual Meeting, advancing ...